DE69609325D1 - Derivate des radicicols - Google Patents

Derivate des radicicols

Info

Publication number
DE69609325D1
DE69609325D1 DE69609325T DE69609325T DE69609325D1 DE 69609325 D1 DE69609325 D1 DE 69609325D1 DE 69609325 T DE69609325 T DE 69609325T DE 69609325 T DE69609325 T DE 69609325T DE 69609325 D1 DE69609325 D1 DE 69609325D1
Authority
DE
Germany
Prior art keywords
represents hydrogen
alkenoyl
alkanoyl
present
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69609325T
Other languages
English (en)
Other versions
DE69609325T2 (de
Inventor
Tsutomu Agatsuma
Yutaka Saitoh
Yoshinori Yamashita
Tamio Mizukami
Shiro Akinaga
Katsushige Gomi
Kazuhito Akasaka
Isami Takahashi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
KH Neochem Co Ltd
Original Assignee
Kyowa Hakko Kogyo Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Co Ltd filed Critical Kyowa Hakko Kogyo Co Ltd
Application granted granted Critical
Publication of DE69609325D1 publication Critical patent/DE69609325D1/de
Publication of DE69609325T2 publication Critical patent/DE69609325T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D313/00—Heterocyclic compounds containing rings of more than six members having one oxygen atom as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Transplantation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Flanged Joints, Insulating Joints, And Other Joints (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
DE69609325T 1995-04-26 1996-04-26 Derivate des radicicols Expired - Fee Related DE69609325T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP10262695 1995-04-26
PCT/JP1996/001158 WO1996033989A1 (fr) 1995-04-26 1996-04-26 Derives de radicicol

Publications (2)

Publication Number Publication Date
DE69609325D1 true DE69609325D1 (de) 2000-08-17
DE69609325T2 DE69609325T2 (de) 2000-11-23

Family

ID=14332458

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69609325T Expired - Fee Related DE69609325T2 (de) 1995-04-26 1996-04-26 Derivate des radicicols

Country Status (13)

Country Link
US (1) US5977165A (de)
EP (1) EP0823429B1 (de)
JP (1) JP3938936B2 (de)
KR (1) KR19990008051A (de)
AT (1) ATE194610T1 (de)
AU (1) AU700840B2 (de)
CA (1) CA2218981C (de)
DE (1) DE69609325T2 (de)
ES (1) ES2149468T3 (de)
HU (1) HUP9901344A3 (de)
NO (1) NO974890L (de)
NZ (1) NZ311790A (de)
WO (1) WO1996033989A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ331062A (en) * 1996-10-25 2000-05-26 Kyowa Hakko Kogyo Company Ltd Radicicol derivatives or pharmacologically acceptable salts which show tyrosine kinase inhibition activity and have antitumor effects
WO1999005136A1 (en) * 1997-07-25 1999-02-04 The Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Macrocyclic lactones, compositions, and methods of use
WO1999055689A1 (fr) * 1998-04-24 1999-11-04 Kyowa Hakko Kogyo Co., Ltd. Derives de radicicol
GB9822450D0 (en) * 1998-10-14 1998-12-09 Smithkline Beecham Plc Medicaments
CA2356622A1 (en) 1998-12-24 2000-07-06 Novation Pharmaceuticals Inc. Compounds which affect mrna stability and uses therefor
GB9914486D0 (en) 1999-06-21 1999-08-18 Smithkline Beecham Plc Medicaments
GB9917406D0 (en) 1999-07-23 1999-09-22 Smithkline Beecham Plc Compounds
GB9917408D0 (en) 1999-07-23 1999-09-22 Smithkline Beecham Plc Compounds
PL366335A1 (en) 2000-07-26 2005-01-24 Smithkline Beecham P.L.C. Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity
EP1315732B1 (de) * 2000-08-25 2006-06-07 Sloan-Kettering Institute For Cancer Research Radicicol und monocillin und ihre analogen und ihre anwendungen
GB0101577D0 (en) 2001-01-22 2001-03-07 Smithkline Beecham Plc Compounds
JP2004529188A (ja) * 2001-05-23 2004-09-24 スローン − ケッタリング インスティチュート フォー キャンサー リサーチ 上昇に関連した癌の治療法
GB0112836D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
GB0112834D0 (en) 2001-05-25 2001-07-18 Smithkline Beecham Plc Medicaments
US20040192638A1 (en) * 2001-07-02 2004-09-30 Oaks John A. Method and composition for prolonging the residence time of drugs in the gut
US7312212B2 (en) 2002-01-29 2007-12-25 Glaxo Group Limited Aminopiperidine derivatives
EP1470131A2 (de) 2002-01-29 2004-10-27 Glaxo Group Limited "aminopiperidinverbindugen, verfahren zu deren herstellung und diese enthaltende pharmazeutische zusammensetzungen "
EP1642880B1 (de) 2003-06-27 2013-09-04 Kyowa Hakko Kirin Co., Ltd. Proteininhibitoren der hsp90-familie
JPWO2005018674A1 (ja) * 2003-08-22 2006-10-19 協和醗酵工業株式会社 イムノグロブリン遺伝子の転座を伴う疾患の治療薬
WO2005061481A1 (en) * 2003-12-19 2005-07-07 Sloan-Kettering Institute For Cancer Research Novel ma crocycles and uses thereof
WO2008021213A1 (en) 2006-08-11 2008-02-21 Nicolas Winssinger Macrocyclic compounds useful as inhibitors of kinases and hsp90
US20110190237A1 (en) * 2008-01-15 2011-08-04 Nexgenix Pharmaceuticals Macrocyclic Prodrug Compounds Useful as Therapeutics
MX2010007755A (es) * 2008-01-15 2010-12-21 Univ Strasbourg Sintesis de lactonas de acido resorcilico utiles como agentes terapeuticos.
CN102015673B (zh) 2008-02-21 2014-10-29 昂科协同公司 用作治疗剂的大环前药化合物
WO2016196256A2 (en) 2015-06-04 2016-12-08 University Of North Carolina At Greensboro Non-aromatic difluoro analogues of resorcylic acid lactones

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4228079A (en) * 1978-10-30 1980-10-14 W. R. Grace & Co. Dialkoxy monorden derivatives
IE911915A1 (en) * 1990-06-06 1991-12-18 Sankyo Co Radicicol derivatives, their preparation and their¹anti-tumor activity
GB9225396D0 (en) * 1992-12-04 1993-01-27 Sandoz Ltd Improvements in or relating to organic compounds

Also Published As

Publication number Publication date
EP0823429B1 (de) 2000-07-12
CA2218981C (en) 2007-01-16
NZ311790A (en) 1999-04-29
HUP9901344A2 (hu) 2001-04-28
AU700840B2 (en) 1999-01-14
EP0823429A4 (de) 1998-07-08
NO974890L (no) 1997-12-29
HUP9901344A3 (en) 2001-05-28
AU6292796A (en) 1996-11-18
CA2218981A1 (en) 1996-10-31
WO1996033989A1 (fr) 1996-10-31
DE69609325T2 (de) 2000-11-23
KR19990008051A (ko) 1999-01-25
NO974890D0 (no) 1997-10-23
JP3938936B2 (ja) 2007-06-27
ATE194610T1 (de) 2000-07-15
EP0823429A1 (de) 1998-02-11
US5977165A (en) 1999-11-02
ES2149468T3 (es) 2000-11-01

Similar Documents

Publication Publication Date Title
ATE194610T1 (de) Derivate des radicicols
SG44794A1 (en) Novel peptide derivatives
DE69728974D1 (de) Radicicolderivate
AU9281198A (en) Benzofuran derivatives
AU5269593A (en) Bicyclic amine derivatives
ES2123873T3 (es) Pirrolocarbazol.
DE69001111D1 (de) Antikrebs-zusammensetzung.
ATE246686T1 (de) Pyrrolocarbazolderivate
ATE105565T1 (de) Pradimicinderivate.
AU1424795A (en) Indole derivative
DE69601451T2 (de) UCK14-Verbindungen
DE69921141D1 (de) Lk6-a-derivate
DE69303847D1 (de) Indolderivate
EP0573659A4 (en) Pyrazolothiazolopyrimidine derivative
DK0455899T3 (da) Prostaglandin I-analog

Legal Events

Date Code Title Description
8339 Ceased/non-payment of the annual fee